Robert A. Forder

1.0k total citations
29 papers, 890 citations indexed

About

Robert A. Forder is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Robert A. Forder has authored 29 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Biochemistry. Recurrent topics in Robert A. Forder's work include Inflammatory mediators and NSAID effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Regulation of Appetite and Obesity (5 papers). Robert A. Forder is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Regulation of Appetite and Obesity (5 papers). Robert A. Forder collaborates with scholars based in United Kingdom, United States and Netherlands. Robert A. Forder's co-authors include F. Carey, J.R.S. Hoult, M. José Alcaraz, Frank Carey, Paul J. L. M. Strijbos, Fred J.H. Tilders, N. J. Rothwell, Nancy J. Rothwell, C.T. O'Shaughnessy and Jane K. Relton and has published in prestigious journals such as The Journal of Experimental Medicine, Biochemical Journal and Brain Research.

In The Last Decade

Robert A. Forder

28 papers receiving 842 citations

Peers

Countries citing papers authored by Robert A. Forder

Since Specialization

Citations

This map shows the geographic impact of Robert A. Forder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Forder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Forder more than expected).

Fields of papers citing papers by Robert A. Forder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Forder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Forder. The network helps show where Robert A. Forder may publish in the future.

Co-authorship network of co-authors of Robert A. Forder

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Forder. A scholar is included among the top collaborators of Robert A. Forder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Forder. Robert A. Forder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Informational Requirements for Transcriptional Regulation 2014 ·Journal of Computational Biology ·(unknown), Robert A. Forder, Ivan Erill	4
2	Expression and purification of biologically active IGF-binding proteins using the LCR/Mel expression system 2002 ·Protein Expression and Purification ·(unknown), Paul T. Sharpe, Peter Newham, (unknown), (unknown), (unknown), Robert A. Forder, M. Needham	5
3	Inhibition of Leukocyte Eicosanoid Generation and Radical Scavenging Activity by Gnaphalin, a Lipophilic Flavonol Isolated from Helichrysum picardii 1999 ·Planta Medica ·R. de la Puerta, Robert A. Forder, J.R.S. Hoult	19
4	The role of lipocortin‐1 in dexamethasone‐induced suppression of PGE₂ and TNFα release from human peripheral blood mononuclear cells 1996 ·British Journal of Pharmacology ·(unknown), Frank Carey, Robert A. Forder, Nancy J. Rothwell	46
5	Lipocortin-1 inhibits CRH stimulation of plasma ACTH and IL-1 beta-stimulated hypothalamic CRH release in rats 1996 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·(unknown), F. Carey, Robert A. Forder, N. J. Rothwell	3
6	Inhibition of Leucocyte 5‐Lipoxygenase and Cyclo‐oxygenase but not Constitutive Nitric Oxide Synthase by Tanetin, a Novel Flavonol Derived from Feverfew, Tanacetum parthenium 1995 ·Pharmacy and Pharmacology Communications ·J.R.S. Hoult, Linhua Pang, Philip Bland‐Ward, Robert A. Forder, Christine A. Williams, Jeffrey B. Harborne	3
7	Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation 1994 ·Inflammation Research ·J.R.S. Hoult, Robert A. Forder, Beatriz de las Heras, (unknown), Miguel Payá	40
8	The local anti‐inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1 1993 ·British Journal of Pharmacology ·G S Duncan, Susan H. Peers, F. Carey, Robert A. Forder, R.J. Flower	40
9	Evidence for the presence and location of annexins in human platelets 1992 ·Biochemical and Biophysical Research Communications ·Christine Murphy, Susan H. Peers, Robert A. Forder, Roderick J. Flower, Frank Carey, John Westwick	19
10	Colony stimulating factor-1 stimulates Ishikawa cell proliferation and lipocortin II synthesis 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·Jamie D. Croxtall, Jeffrey W. Pollard, F. Carey, Robert A. Forder, J.O. White	14
11	Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. 1991 ·The Journal of Experimental Medicine ·Jane K. Relton, Paul J. L. M. Strijbos, C.T. O'Shaughnessy, F. Carey, Robert A. Forder, Fred J.H. Tilders, N. J. Rothwell	120
12	Differential regulation of 5‐lipoxygenase and cyclo‐oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes 1990 ·British Journal of Pharmacology ·(unknown), Robert A. Forder, F. Carey, J.R.S. Hoult	11
13	Radioimmunoassay of LTB4 in plasma from different species: A cautionary note 1989 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·F. Carey, Robert A. Forder, Kimberley Gibson, (unknown)	8
14	Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors 1988 ·Journal of Pharmacological Methods ·Frank Carey, (unknown), (unknown), Robert A. Forder	8
15	Selectivity of Neutrophil 5-Lipoxygenase and Cyclo-oxygenase Inhibition by an Anti-inflammatory Flavonoid Glycoside and Related Aglycone Flavonoids 1988 ·Journal of Pharmacy and Pharmacology ·(unknown), M. José Alcaraz, Robert A. Forder, F. Carey, J.R.S. Hoult	293
16	Leukotriene B4 production in human atherosclerotic plaques. 1988 ·PubMed ·R De Caterina, Annamaria Mazzone, Daniela Giannessi, Rosa Sicari, (unknown), Guido Lazzerini, Antonio Azzarà, Robert A. Forder, F. Carey, Damiano Caruso	47
17	Identification and measurement of 12-hydroxy-5,8,10,14-eicosatetraenoic acid in whole blood: implications for the radioimmunoassay of leukotriene B4 1987 ·Biochemical Society Transactions ·F. Carey, Robert A. Forder, (unknown), P.M. Woollard	2
18	Radioinmunoassay of LTB4 and 6-trans LTB4: Analytical and pharmacological characterisation of immunoreactive LTB4 in ionophore stimulated human blood 1986 ·Prostaglandins Leukotrienes and Medicine ·Frank Carey, Robert A. Forder	32
19	Human 5-lipoxygenase: Measurement by radioimmunoassay of LTB4 in calcium ionophore stimulated blood 1984 ·Prostaglandins ·Robert A. Forder, Frank Carey	9
20	Measurement OF Human venous plasma prostacyclin and metabolites by radioimmunoassay: A reappraisal 1983 ·Prostaglandins Leukotrienes and Medicine ·Robert A. Forder, Frank Carey	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact